Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Journal of Pharmacopoeia

Pharmaceutical involvement in Infectious Disease control: Strategies, Challenge and Solutions Norma Winata; Dadang Muhammad Hasyim; Brevmana Anugrah Primulyanto
Journal of Pharmacopoeia Vol. 1 No. 2 (2024): SEPTEMBER-JP
Publisher : Pt. Anagata Sembagi Education

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62872/rtag4g06

Abstract

This study aims to explore the role of the pharmaceutical sector in controlling infectious diseases, focusing on strategies, challenges, and solutions that can be implemented. The research method used is Systematic Literature Review (SLR) to collect and analyze data from related literature. Inclusion criteria include articles published in the last ten years, using English or Indonesian, and discussing pharmaceutical strategies in controlling infectious diseases. The literature search process was carried out through scientific databases such as PubMed, Scopus, and Google Scholar. The results of this study are Infectious disease control strategies involve the development of new vaccines and drugs, efficient drug distribution, and public education. The pharmaceutical sector plays an important role in creating medical solutions and implementing vaccination campaigns. The main challenge is antimicrobial resistance, which is caused by the unwise use of antibiotics. To overcome this challenge, public education, strict supervision in health facilities, and the development of new drugs are needed. The application of digital technology, such as AI-based applications, can also help monitor drug use and provide early warnings about the spread of disease. The role of pharmacists is vital in providing information and education about disease prevention, correct drug use, and the importance of vaccination. With innovative solutions such as the development of emergency pharmaceutical packages, the implementation of e-prescription, and technology-based training for pharmacists, it is hoped that the global health system can be more resilient in dealing with infectious disease outbreaks. Collaboration between the pharmaceutical sector, governments, and international organizations is essential in strengthening infectious disease control efforts and improving the readiness of the global health system.
Evidence-Based Pharmacy: Integration of Data and Research in the Development of more Effective and Safer Drugs Dadang Muhammad Hasyim; Liza Rastiti
Journal of Pharmacopoeia Vol. 1 No. 2 (2024): SEPTEMBER-JP
Publisher : Pt. Anagata Sembagi Education

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62872/29d66p06

Abstract

The main objective of this study was to collect, evaluate, and synthesize findings from relevant studies on the use of evidence-based data in drug development. The method used was a Qualitative Systematic Literature Review (SLR), which focused on understanding in-depth how the integration of data from clinical trials, big data, and laboratory studies can improve drug efficacy and safety. Through this approach, the study identified experiences, perceptions, and findings in the literature on drug development, and how this evidence supports decisions in drug selection and testing. The results showed that evidence-based pharmacy has great potential to improve the efficacy and safety of therapies by leveraging the integration of data from various sources and advanced analytical technologies. This approach can address key challenges in modern pharmacy, such as drug resistance and patient response variability, and result in more personalized and effective therapies. However, the implementation of evidence-based pharmacy requires support from various stakeholders, including academia, industry, and policy makers. Challenges such as data interoperability and privacy protection need to be addressed to ensure wider adoption. With a strategic and collaborative approach, evidence-based pharmacy can be the foundation for better precision medicine in the future, providing significant benefits to patients worldwide.
Co-Authors Abdul Rosid Ahmad Izuddin Andy Rachman ansori ansori Ardi, Abdullah Arief Budi Pratomo Arnes Yuli Vandika Asmaret, Desi Astuti, Aldiana Azhariah Rachman Baiq Ayu Aprilia Mustariani Bansaleng, Yessikah Feiby Brevmana Anugrah Primulyanto Cecep Hilman Dani Sujana Dede Suharta Desty Endrawati Subroto Devi Rahmah Sope Dhaniswara, Erwin Diah Wardani Dina Nirwana Suwinda, Dina Nirwana Suwinda Dito Anurogo, Dito Eka Selvi Handayani Eka Selvi Handayani, Eka Selvi Elang Mohamad Atoilah Elvina Triana Putri Eny Retna Ambarwati Erlinawati, Noor Diah Euis Kusumarini Firman Muharam Fitriah Handayani Gina Nafsa Mutmainna, Gina Nafsa Mutmainna Habibi Hafid, Hendra Hamzah Puadi Ilyas, Hamzah Puadi Hendra Nusa Putra Hesti Renggana Hiola, Siti Fatmah Irma Muti Irmanida Batubara Iwan Aprianto Izuddin, Ahmad Judijanto, Loso Kusumarini, Euis La Ode Maksar Muhuruna Legito Liza Rastiti Melinda Arismawati Mena Sari Mina Pertiwi Moh. Imron Rosidi Muntasir, Muntasir Muslimin Muslimin Najamuddin Petta Solong Natalia Lisma Br Sembiring Nazaruddin Ahmad Norma Winata Novelti, Novelti Novycha Auliafendri Nuralfin Anripa Nurul Oktafian Farhan Ramdani, Hasbi Taobah Ramson Rikson Maruwahal Sijabat Rian Novita Ridayani, Ridayani Riniati, Wa Ode S. Sumihatul Ummah MS, S. Sumihatul Ummah Salma Nurin Fadilah Santi Yuliasari Saputra, Abiyasa Eka Siti Aisyah Hanim, Siti Aisyah Solehuddin, Moh. STIKES Karsa Husada Garut Subroto, Desty Endrawati Sulaeman Sulaminingsih, Sulaminingsih Sumerli A, Chevi Herli Supriatnini, Ai Susatyo Adhi Pramono, Susatyo Adhi Sutrisno Sutrisno Sutrisno Sutrisno Syamsu Rijal Syamsul Anwar Syamsul Anwar, Syamsul Tarru, Harni Eirene Tarru, Reni Oktaviani Trisna Rukhmana Wiwid Suryono Yogi Rahman Nugraha Zahara Farhan Zakka, Umar Zani, Benny Novico